Consolidated Statement Of Cash Flows

Kohjin Bio Co., Ltd. - Filing #7320495

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,321,461,000 JPY
922,994,000 JPY
Interest and dividends received
832,000 JPY
641,000 JPY
Interest paid
-23,238,000 JPY
-32,434,000 JPY
Income taxes paid
-475,375,000 JPY
-430,048,000 JPY
Net cash provided by (used in) operating activities
823,681,000 JPY
461,153,000 JPY
Cash flows from investing activities
Purchase of securities
JPY
-9,999,000 JPY
Purchase of property, plant and equipment
-562,554,000 JPY
-560,664,000 JPY
Net cash provided by (used in) investing activities
-577,354,000 JPY
-575,459,000 JPY
Loan advances
JPY
-7,000,000 JPY
Proceeds from collection of loans receivable
JPY
7,000,000 JPY
Cash flows from financing activities
Proceeds from short-term borrowings
600,000,000 JPY
600,000,000 JPY
Repayments of short-term borrowings
-300,000,000 JPY
-300,000,000 JPY
Dividends paid
-79,135,000 JPY
-41,650,000 JPY
Proceeds from long-term borrowings
750,000,000 JPY
JPY
Repayments of long-term borrowings
-939,800,000 JPY
-409,600,000 JPY
Net cash provided by (used in) financing activities
-1,348,000 JPY
-172,209,000 JPY
Effect of exchange rate change on cash and cash equivalents
19,392,000 JPY
14,593,000 JPY
Net increase (decrease) in cash and cash equivalents
264,369,000 JPY
-271,921,000 JPY
Cash and cash equivalents
1,726,936,000 JPY
1,462,566,000 JPY
1,734,488,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.